My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
June 2011
Patient Care and Science
Drug Approvals, Recalls, Adverse Events Update

IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Content includes a range of topics, including new drug approvals and warnings. Recent alerts have included:

IDSA members can sign up for these services online. (You must be logged in to have access to this link.)


Is Your Facility Experiencing Antibiotic Shortages?
Report these to FDA and IDSA.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
IDSA Practice Guideline Translations Now Online
EIN Update: Syphilitic Scleritis and Screening Dilemmas for Syphilis
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Report Details Participation and Payment Amounts for CMS Incentive Programs
Global ID
UN AIDS Declaration Sets Ambitious Goals, Falls Short in Some Areas
Drs. John G. Bartlett, Wafaa El-Sadr, Eric Goosby, and Others Reflect on 30 Years of AIDS
Policy and Advocacy
IDSA Addresses Adult Vaccination
HHS Seeks Input on HIPAA’s Regulatory Burden on Research
New Bills Focus on Incentives for Antibiotic Development and Home Infusion Therapy Coverage
Your Colleagues
Members on the Move
Welcome, New Members!
Education & Resources
ID and HIV Maintenance of Certification Modules Available
ID/HIV Career Center Helps You Meet Your Match
Top Stories
From the President: Improving Communication With Members
Changes Needed to Allow Reimbursement for ID Physicians’ Systems-Level Activities, IDSA Says
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.